TrialFind
SearchAbout
Saved trials

Filters

Sort by

Recruitment

Status

Phase

Age group

TrialFind

Making clinical research accessible to everyone. Search 500,000+ trials in plain English.

NavigationHomeSearch TrialsAboutSaved Trials
Data & LegalClinicalTrials.govPrivacyRegulatory infoContact

© 2025 TrialFind. Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

CompletedPhase 1

Absorption, Distribution, Metabolism and Excretion of [14C]-Labelled BIA 3-202 and Metabolites

The purpose of this study is: To determine the rate and routes of excretion of BIA 3-202 and the mass balance in urine and faeces To determine the kinetics of total radioactivity in blood To determine the kinetics of total radioactivity in

Allschwil, Basel, Switzerland
View details
Load more trials
CompletedN/A

Effect Mechanism Investigation of a Non-invasive Stimulation Device for Rapid Alleviation of Parkinson's Disease Symptoms

Effect Mechanism Investigation of a Wearable Electrostimulator for Rapid Alleviation of Parkinson's Disease Symptoms

Istanbul, Turkey (Türkiye)
View details
CompletedN/A

Subthalamotomy by ExAblate Transcranial System to Treat Motor Features of Parkinson's Disease

Based on published animal and human studies, ExAblate Transcranial subthalamotomy can be as safe and as effective as any of the surgical treatments within the currently accepted standard of care including radiofrequency lesioning and Deep B

Multiple locations
View details
Completed

Transcranial Magnetic Stimulation in Parkinson's Disease

This study will use transcranial magnetic stimulation (TMS) to explore how the brain controls movement by sending messages to the spinal cord and muscles and what goes wrong with this process in disease. Activity in the motor cortex-the out

Bethesda, Maryland, United States
View details
Completed

Smartphone-based Wearable Telerehabilitation

Parkinson's disease (PD), one of the most common neurological disorders, affects at least 10 million people worldwide. The cardinal motor impairments are tremor, bradykinesia, muscle rigidity, and postural instability.

Houston, Texas, United States
View details
CompletedN/A

Neurostimulation for Dysphagia in Parkinson's Disease

This study will explore the effects of 3 different neurostimulation methods on swallowing function in patients with dysphagia secondary to Parkinson's Disease

Salford, Manchester, United Kingdom
View details
CompletedPhase 1

Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease

This randomized study was designed to evaluate the efficacy and safety of IPu-infused liatermin (15mg/putamen/day) compared with placebo in subjects with symptomatic, levodopa-response Parkinson's disease. This study consisted of a 90-day e

Multiple locations
View details
Not yet recruitingPhase 1 / Phase 2

Terazosin And Metabolic Engagement in Parkinson's Disease

To assess target engagement of terazosin (TZ) at multiple doses (1 mg/day, 3 mg/day, and 5 mg/day) and to assess sustained target engagement over 6 months relative to placebo in patients with Parkinson's Disease (PD). Target engagement will

Multiple locations
View details
CompletedPhase 4

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis

Scottsdale, Arizona, United States+17 more
View details
UnknownN/A

The Effect of LSVT LOUD for Mandarin-speaking Individuals With Hypokinetic Dysarthria Due to Parkinson's Disease

A handful of studies have examined the effects of the Lee Silverman Voice Treatment (LSVT) LOUD on hypokinetic dysarthria in English speakers with Parkinson's disease (PD). Although LSVT LOUD has been found to be effective on improving thes

Taipei, Taiwan, Taiwan
View details
Withdrawn

Optimizing DBS Electrode Placement and Programming

Deep brain stimulation (DBS) has become the primary surgical therapy for the treatment of motor symptoms associated with Parkinson's disease (PD), and for essential tremor (ET). Although an effective and relatively safe procedure with expan

Aurora, Colorado, United States+1 more
View details
CompletedN/A

UPDRS-III Comparisons of DBS for PD Between Patients Receiving MAC and AAA Anesthesia

Compares the patients' scores of UPDRS-III before and six-month after receiving deep brain stimulation for Parkinson's disease under MAC or AAA anesthesia.

Shenzhen, Guangdong, China
View details
Recruiting

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

This registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years. The proposed registry will enroll 60 subjects and will be conducte

Baltimore, Maryland, United States+4 more
View details
UnknownN/A

Effects of an Innovative Balance Training Programme in Enhancing Postural Control and Reducing Falls in Patients With Parkinson's Disease

Falling is a complex and most disabling feature for patients with Parkinson's disease (PD). Previous studies suggested that falls in patients with PD are related to postural instability characterized by deficits in anticipatory postural adj

Hong Kong, Hong Kong, China
View details
CompletedPhase 1

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

The purpose of this study is to assess the pharmacokinetics (PK) of BIA 9-1067 in patients with moderate chronic hepatic impairment and in matched healthy subjects.

Rennes, France+2 more
View details
UnknownN/A

The Calgary Movement Disorders Advanced Care Pilot Program

The goal of this clinical trial is to analyse the effect of palliative care interventions on quality of life, patient satisfaction, carepartner burden and health care utilization patterns in patients living with parkisonism and their carepa

Calgary, Alberta, Canada
View details
RecruitingN/A

Experimental Pain in Parkinsons

Study comparing pain intensity and discomfort in patients with Parkinson´s disease and healthy controls during inducement of mechanical, thermal, and chemical experimental pain

Aarhus, Denmark
View details
CompletedN/A

Evaluation of Intensive Language Therapy

Due to Parkinson's Disease (PD) speech and language (SL) deficits may occur. Further, the literature reports that PD patients, who have not undergone deep brain stimulation (DBS), have deficits regarding voice quality (e.g.

Basel, Canton of Basel-City, Switzerland
View details
Withdrawn

A Prospective Longitudinal Assessment of PD Functional Impairment and Disability Via Mobile Health Technology

The purpose of this study is to compare data from a battery of novel mobile health technologies to standard-of-care validated patient questionnaires and clinician rating scales in Parkinson's disease patients.

Multiple locations
View details
CompletedPhase 3

Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person.

Birmingham, Alabama, United States+75 more
View details